Skip to product information
1 of 1

Cloud-clone

SKU:PAB481Ra01

Polyclonal Antibody to N-cadherin (NCAD)

Polyclonal Antibody to N-cadherin (NCAD)

Regular price $362.00 USD
Regular price Sale price $362.00 USD
Sale Sold out
Shipping calculated at checkout.
UOM
Concentration
Organism species

Western blotting: 0.5-2µg/mL;1:400-1700
;Immunohistochemistry: 5-20µg/mL;1:40-170
;Immunocytochemistry: 5-20µg/mL;1:40-170
;Optimal working dilutions must be determined by end user.

Product No.

PAB481Ra01

Organism Species

Rattus norvegicus (Rat).

Source

Polyclonal antibody preparation

Host

Rabbit

Potency

n/a

Ig Type

IgG

Purification

Antigen-specific affinity chromatography followed by Protein A affinity chromatography

Label

None

Immunogen

RPB481Ra01-Recombinant N-cadherin (NCAD)

Buffer Formulation

0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.

Traits

Liquid

Concentration

500µg/mL

Organism Species More

Homo sapiens (Human), Mus musculus (Mouse)

Applications

WB; IHC; ICC; IP.

If the antibody is used in flow cytometry, please check FCM antibodies.

UOM

20µl 100µl 200µl 1ml 10ml

SPECIFITY

The antibody is a rabbit polyclonal antibody raised against NCAD. It has been selected for its ability to recognize NCAD in immunohistochemical staining and western blotting.

USAGE

Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

STORAGE

Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Magazine

Citations

Toxicology Letters

Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients. Pubmed: 23830989

British journal of haematology

Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma. Pubmed: 23438504

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Elevated Cerebrospinal Fluid and Plasma N-Cadherin in Alzheimer Disease Pubmed: 32296844

Cell Biol Toxicol

ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer 33566221

CELL BIOLOGY AND TOXICOLOGY

Metastatic suppression by DOC2B is mediated by inhibition of epithelial-mesenchymal transition and induction of senescence 33758996

Pharmacol Res

DOC2B is a Negative Regulator of Wnt/β-catenin Signaling Pathway in Cervical Cancer Pubmed:35500882


Catalog No.

Related products for research use of Rattus norvegicus (Rat) Organism species

Applications (RESEARCH USE ONLY!)

RPB481Ra02

Recombinant N-cadherin (NCAD)

Positive Control; Immunogen; SDS-PAGE; WB.

RPB481Ra03

Recombinant N-cadherin (NCAD)

Positive Control; Immunogen; SDS-PAGE; WB.

RPB481Ra01

Recombinant N-cadherin (NCAD)

Positive Control; Immunogen; SDS-PAGE; WB.

PAB481Ra02

Polyclonal Antibody to N-cadherin (NCAD)

WB; IHC; ICC; IP.

PAB481Ra03

Polyclonal Antibody to N-cadherin (NCAD)

WB; IHC; ICC; IP.

PAB481Ra01

Polyclonal Antibody to N-cadherin (NCAD)

WB; IHC; ICC; IP.

LAB481Ra71

Biotin-Linked Polyclonal Antibody to N-cadherin (NCAD)

WB; IHC; ICC.

 

View full details